Associated Papers
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.
Oliveira M et al.
Antimicrobial Agents and Chemotherapy, 2009
Select a paper to view details